<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00347321</url>
  </required_header>
  <id_info>
    <org_study_id>P051013</org_study_id>
    <nct_id>NCT00347321</nct_id>
  </id_info>
  <brief_title>Early Percutaneous Tracheostomy for Cardiac Surgery (ETOC)</brief_title>
  <acronym>ETOC</acronym>
  <official_title>Evaluation of Early Percutaneous Tracheostomy in Patients Undergoing Cardiovascular Surgery and Requiring Prolonged Mechanical Ventilation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a phase III clinical trial comparing early tracheostomy (day 4) versus prolonged&#xD;
      endotracheal intubation in ICU patients needing prolonged ventilatory support after&#xD;
      cardiovascular surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: Prolonged mechanical ventilation (MV&gt; 7 days) is required in less than 10% of&#xD;
      patients after cardiovascular surgery but it is associated with high morbidity and mortality.&#xD;
&#xD;
      Several studies conducted in critically ill patients suggested that early percutaneous&#xD;
      tracheotomy compared with delayed tracheotomy decreases the length of ventilator dependence&#xD;
      and improves outcome. To date, no randomized trial has tested these possible benefits in&#xD;
      critically ill patients after cardiac surgery.&#xD;
&#xD;
      Study objectives: A randomized trial has been designed to determine whether early&#xD;
      tracheostomy (day 4 after cardiac surgery) in patients still on MV would reduce the number of&#xD;
      days under MV, measured by the evaluation of ventilator-free days (VFDs). Secondary&#xD;
      objectives are the reduction of mortality, reduction of ICU and hospital length of stay.&#xD;
      Evaluation of organ failure evolution, infectious complications, sedation needs, patient&#xD;
      comfort and outcome at 3 months will be also considered.&#xD;
&#xD;
      Study hypothesis: The trial will be consider positive if early tracheotomy increases the&#xD;
      number VFDs of at least 7 days (mean) evaluated on day 60 after randomisation.&#xD;
&#xD;
      Methods :&#xD;
&#xD;
      Trial : randomized, open, controlled, monocentric Inclusion criteria: see columns below&#xD;
      Exclusion criteria: see columns below Randomization: will use a computerised system on day 4&#xD;
      after cardiac surgery Procedures: see columns below Recorded data: demographic&#xD;
      characteristics, pre, per and postoperative parameters.&#xD;
&#xD;
      From randomization until ICU discharge (or day 60), a daily chart will be completed.&#xD;
&#xD;
      Judgment criteria: see columns below Sample size and statistical analysis: using Wilcoxon&#xD;
      bilateral test with an alpha risk of 5% and a power of 80%, we calculated that 108 patients&#xD;
      in each arm would be needed.&#xD;
&#xD;
      Statistical analyses will use standard tests to compare population of the two arms.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2006</start_date>
  <completion_date type="Actual">June 2009</completion_date>
  <primary_completion_date type="Actual">March 2009</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of ventilator-free days defined as the number of days between successful weaning from MV and day 60 after study enrolment.</measure>
    <time_frame>between successful weaning from MV and day 60 after study enrolment.</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>VFDs = 0 if the patient dies before 60days.</measure>
    <time_frame>before 60 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>VFDs= (60- X) : if the patient is successfully weaned from MV within 60 days, where X is the number of days spent receiving MV</measure>
    <time_frame>during 60 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>VFDs = 0: if the patient requires MV for 60 days or more</measure>
    <time_frame>during 60 days and after</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>The trial will be considered positive if early tracheostomy increases the number VFDs of at least 7 days (mean)</measure>
    <time_frame>at 7 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Other outcomes will be compared between the two arms:</measure>
    <time_frame>during the trial</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality rate (day 60, in-ICU, in-hospital)</measure>
    <time_frame>during the 60 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU length of stay</measure>
    <time_frame>during the trial</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital length of stay</measure>
    <time_frame>during the trial</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of MV in survivors</measure>
    <time_frame>during the trial</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Organ failure evolution</measure>
    <time_frame>during the trial</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infectious complications</measure>
    <time_frame>during the trial</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Early laryngeal and tracheal complications</measure>
    <time_frame>during the trial</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sedation needs</measure>
    <time_frame>during the trial</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient comfort</measure>
    <time_frame>during the trial</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Outcome on day 90</measure>
    <time_frame>to 90 days</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">212</enrollment>
  <condition>Respiratory Failure</condition>
  <condition>Cardiovascular Surgery</condition>
  <arm_group>
    <arm_group_label>Dilatational Percutaneous tracheostomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dilatational Percutaneous tracheostomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Dilatational Percutaneous tracheostomy</intervention_name>
    <description>Dilatational Percutaneous tracheostomy</description>
    <arm_group_label>Dilatational Percutaneous tracheostomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Are 18 years of age or older&#xD;
&#xD;
          -  Have undergone cardiovascular surgery&#xD;
&#xD;
          -  Are still on invasive mechanical ventilation on day 4 after surgery&#xD;
&#xD;
          -  Have failed the screening test or the spontaneous breathing trial&#xD;
&#xD;
          -  Have signed the informed consent (patient or legal representative)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age less than18&#xD;
&#xD;
          -  Pregnant woman&#xD;
&#xD;
          -  Intubation more than 48 hours before cardiovascular surgery&#xD;
&#xD;
          -  More than 5 days on mechanical ventilation after cardiac surgery&#xD;
&#xD;
          -  Artificial heart implantation&#xD;
&#xD;
          -  Concomitant neck surgery (carotid)&#xD;
&#xD;
          -  Previously tracheostomized&#xD;
&#xD;
          -  Major hemorrhagic risk&#xD;
&#xD;
          -  Persistence of platelet count less than 50.000/mm3 after platelet transfusion&#xD;
&#xD;
          -  Prothrombin time less than 30% despite coagulation factors administration&#xD;
&#xD;
          -  Clinical evidence of ongoing infection at the proposed tracheotomy site&#xD;
&#xD;
          -  Anatomical deformity of the neck making risky a tracheostomy&#xD;
&#xD;
          -  Probability of dying the day of randomization defined by SAPSII more than 80&#xD;
&#xD;
          -  Irreversible neurological lesions&#xD;
&#xD;
          -  Decision of care limitation&#xD;
&#xD;
          -  Prior inclusion in a trial with morbidity-mortality as main judgement criteria&#xD;
&#xD;
          -  Previous enrollment in this trial&#xD;
&#xD;
          -  Consent refusal&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean Louis TROUILLET, MD,</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institut de Cardiologie - Chu Pitie Salpetriere Ap-Hp</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2007</verification_date>
  <study_first_submitted>June 29, 2006</study_first_submitted>
  <study_first_submitted_qc>June 29, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 4, 2006</study_first_posted>
  <last_update_submitted>December 2, 2009</last_update_submitted>
  <last_update_submitted_qc>December 2, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 3, 2009</last_update_posted>
  <responsible_party>
    <name_title>Christophe AUCAN</name_title>
    <organization>Department Clinical Research of Developpement</organization>
  </responsible_party>
  <keyword>Percutaneous tracheostomy</keyword>
  <keyword>Endotracheal intubation</keyword>
  <keyword>Mechanical ventilation</keyword>
  <keyword>Cardiac surgery</keyword>
  <keyword>Ventilator-free days</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

